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This report describes the fabrication of a novel microfluidics nanobiochip based on a composite comprising
of nickel oxide nanoparticles (nNiO) and multiwalled carbon nanotubes (MWCNTs), as well as the chip’s use
in a biomedical application. This nanocomposite was integrated with polydimethylsiloxane (PDMS)
microchannels, which were constructed using the photolithographic technique. A structural and
morphological characterization of the fabricated microfluidics chip, which was functionalized with a
bienzyme containing cholesterol oxidase (ChOx) and cholesterol esterase (ChEt), was accomplished using
X-ray photoelectron spectroscopy (XPS) and scanning electron microscopy. The XPS studies revealed that
9.3% of the carboxyl (COOH) groups present in the nNiO-MWCNT composite are used to form amide bonds
with the NH2 groups of the bienzyme. The response studies on this nanobiochip reveal good reproducibility
and selectivity, and a high sensitivity of 2.2 mA/mM/cm2. This integrated microfluidics biochip provides a
promising low-cost platform for the rapid detection of biomolecules using minute samples.
T
he ability to monitor desired biomolecules in real time via a microfluidics biochip or a micro-total analytical
system (m-TAS) has aroused considerable interest from the point-of-care (POC) diagnostics community1,2.
The small geometry of a microfluidics biochip offers many advantages over macroelectrode-based biome-
dical devices due to its improved mass transport and diffusion, high signal-to-noise ratio, and low detection
limit3,4. The characteristics of nanocomposites and the intrinsic benefits of microfluidics, including their laminar
flow, low consumption of costly reagents and power, portability, minimal need for handling biohazardous
materials, fast response time, multiplexing, and parallelization, are advantageous for the fabrication of a bio-
chip5,6. The precise liquid control that occurs in a microfluidic platform is essential for the fabrication of micro-
channels. Polydimethylsiloxane (PDMS) is an attractive polymeric material for the fabrication of microchannels,
which can be temporarily sealed with a glass substrate via conformal contact mediated by Van der Waals force.
Additionally, the hydrophobic properties of PDMS provide good chemical compatibility with organic solvents
and cause negligible swelling5,6.
The microfluidics biochip is known to have many applications, such as enzymatic kinetics and immunoassay
analyses; DNA amplification; and cell sorting, culturing, and counting7. However, the integration of the micro-
fluidics biochip with a nanostructured material continues to be a challenge. In this context, 1D structures, such as
nanotubes, nanowires, and nanocomposites, composed of carbon materials can play an important role in medi-
cinal chemistry and diagnostics, including the creation of biochips for in vitro and in vivo investigations3,8–13.
Multiwalled carbon nanotubes (MWCNTs), allotrope of carbon play an important role towards the development
of biochips because of their high carriermobility and tensile strength, as well as their high aspect ratio, which leads
to quantum electron transport12. In addition, MWCNTs are non-reactive (like graphite) except at the nanotube
caps (the tips when they are not cut), where the dangling bonds and edge-plane-like sites located at both ends are
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open to reactions14. TheMWCNTs are known to produce changes in
energy bands close to the Fermi level15,16. The exciting electronic
properties and high electrochemical reactivity of MWCNTs suggest
that fast electron transfer reaction occurs when they are used as the
electrode in an electrochemical biochip15,16. Lin et al. have developed
a microfluidics electrochemical sensor for on-site, non-invasive
monitoring of lead and chlorophenols17. Wisitsoraat et al. have
developed an electrochemical biochip for cholesterol detection that
has a sensitivity of 0.0512 nA/mg/dl, which is attributed to the direct
growth of CNT on glass18. However, MWCNTs are known to
agglomerate via Van der Waals interactions, resulting in poor film-
forming ability. To overcome this problem, nanostructured metal
oxides (NMOx) may be used to control the agglomeration of
MWCNTs19. The covalent binding (or sidewall functionalization)
of biomolecules (e.g., proteins, enzymes, and nucleic acids) to carb-
oxyl-functionalized MWCNTs via diimide-activated amidation may
provide improved stability and reproducibility20–24. In such a case, the
large surface area of the MWCNTs and the presence of abundant
functional groups may offer a suitable platform for biofunctionaliza-
tion20–25. Additionally,MWCNTsmay facilitate continuous conduct-
ing pathways to transport the charge carriers, allowing for a higher
sensitivity25. Shim et al. have used functionalized CNT for biomole-
cular recognition in a streptavidin/biotin approach to investigate the
adsorption of proteins on the sidewalls of carbon nanotubes20.
A biosensor based on nanostructured nickel oxide (nNiO) has
recently been explored to detect biomolecules such as DNA, anti-
body-antigen interactions, glucose, and cholesterol26,27. However,
nNiO-based biosensors have limited applications due to the inher-
ently poor electrical conductivity of nNiO26. The non-covalent
immobilization of enzymes onto nNiO-based biochip has recently
been found to result in poor stability of the desired biomolecules26–28.
To improve the characteristics of a biosensing device, nNiO can be
integratedwithMWCNTs29,30. Zhang et al. have usedCNT-NMOx to
develop solar cells and gas sensors21. The sp2 hybridization and
Figure 1 | (i) The schematic of the microfluidic biochip used for total cholesterol detection (the ordered arrangement of this microsystem is assumed).
(ii) The photograph of real microfluidic biochip for cholesterol detection and (iii) the enlarged view of optical microscopic image of the microfluidic
biochip.
www.nature.com/scientificreports
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electronic properties of nNiO coupled with the specific recognition
properties of immobilized MWCNTs could lead to a miniaturized
biochip29,30. Chen et al. have reported the creation of a non-enzymatic
electrochemical glucose sensor based on aMnO2/MWCNTmatrix29.
Zhu et al. have utilized MWCNTs with ZnO nanoparticles for ultra-
fast, nonlinear optical switching19.
In this study, we discuss the fabrication of a novel nNiO-MWCNT
nanocomposite-based biochip for total cholesterol estimation. The
biochip is immobilized with a bienzyme, composed of cholesterol
esterase (ChEt) and cholesterol oxidase (ChOx), and integrated with
PDMSmicrochannels. Unlike conventional methods, our procedure
creates bienzyme functionalization through the carboxylation and
amidation of the nNiO-MWCNT nanocomposite that serves as the
sensing interface.
Results
To confirm the formation of the nanocomposite (nNiO-MWCNT)
on the microfluidic electrode, we performed X-ray diffraction
(XRD), Raman spectroscopy, X-ray photoelectron spectroscopy
(XPS), zeta potential and electrochemical studies. The XRD studies
of the nNiO-modified MWCNTs (Fig. 2(i)) revealed the purity and
crystallinity of the synthesized NiO nanoparticles with the face-cen-
tered cubic configuration (a) (4.1 A˚) and space group Fm3m (225)
(JCPDS Card No. 78-0423). Figure 2(i) reveals a peak at 26u (2h
value) due to the (002) plane (JCPDS Card No. 75-1261) of the
MWCNTs. However, the peak intensity of the MWCNTs is lower
compared to other peaks due to the presence of defects. The other
peaks observed in the diffraction pattern are attributed to the (111),
(200), (220), (311), and (222) planes of the cubic NiO26. The peak
intensity observed for the (200) plane at 2h (43.3u) is higher than that
of the (111) plane, indicating that the growth is mainly dominated by
the (200) facet. The d200 value of 0.20 nm corresponds to the (200)
plane.
The Raman studies (Fig. 2(ii)) show several bands at 532 nm (the
excitation wavelength). The vibrational band of NiO (spectra (a)),
arising due to one phonon (1P) sampling at 494 cm21, corresponds
to transverse optical (TO) mode. The two-phonon (2P) peak
observed at approximately 746 cm21 is assigned to the 2TO and
2LO (longitudinal optical) modes (at approximately 1027 cm21).
The band observed at approximately 713 cm21 exhibits a low intens-
ity at room temperature (298 K), indicating the presence of NiO. In
spectra (b), two sharp intense peaks attributed to G (graphite) and D
(disorder) bands at 1342 cm21 and 1580 cm21, respectively, can be
observed. The 2D band is found at 2695 cm21 (the second order of
the D band). A small feature near 1617 cm21 can be assigned to the
G2 or D band, and the peaks pertaining to the G 1 D band
(approximately 2942 cm21), as well as a small peak at approximately
2450 cm21, can also be observed. The tangential G band (approxi-
mately 1580 cm21), derived from the graphite-like in-plane mode,
splits into two distinct bands attributed to G1 (1577 cm21). The G2
(1610 cm21) peak arises due to changes in the curvature of the inner
and outer cylinders.
Figure 3(i) shows an XPS wide-scan spectrum obtained for
the nNiO-MWCNT/ITO (subfigure a) and ChEt-ChOx/nNiO-
MWCNT/ITO (sub-figure b) electrodes. The peaks found at 284.6
and 530.6 eV are attributed to the C1s and O1s of the COOH-func-
tionalized MWCNTs. In spectrum (b), the characteristic peak
observed at 399 eV is attributed to the presence of N1s in the bien-
zyme (ChEt-ChOx). The additional peaks found at 66.0, 112.6, 777.6,
870.6, and 1009.0 eV are assigned to Ni 3p3, Ni 3S, Ni-Auger, Ni 2p3,
andNi 2P1, respectively. TheNi 2S peak is due to the incorporation of
NiO onto the MWCNTs. The relative atomic concentrations (%) of
carbon, nitrogen, oxygen, and nickel are summarized in Table I. The
atomic concentration of nitrogen in the ChEt-ChOx/nNiO-
MWCNT/ITO bioelectrode was found to be 9.93%. This result indi-
cates that the nNiO-MWCNT/ITO surface facilitates the covalent
functionalization of ChEt-ChOx via EDC-NHS chemistry. The XPS
spectra of the carbon 1 s region of the deposited nNiO-MWCNT
electrode (Fig. 3(ii)) was deconvoluted into characteristic peaks using
the Shirley-type baseline and Lorentzian-Doniac-Sunsic curves, with
a Gaussian profile. The peak found at 284.1 eV is graphitic (sp2), the
peak at 285.2 eV is due to a defect (sp3), the peak at 286.3 eV is
attributed to a hydroxyl group, the peak at 287.3 eV is assigned to
a carbonyl group and the peak found at 288.2 eV is attributed to the
carboxyl group (-O-C5O). In the ChEt-ChOx/nNiO-MWCNT/
ITO electrode (Fig. 3(iii)), the binding energy peaks corresponding
to functional groups are the same as those clearly visible in the
spectra of the nNiO-MWCNT/ITO electrode. The observed lower
intensities of the ChEt-ChOx electrode, as well as the slight shift in its
binding energy positions (Fig. 3(iii)) compared with those of the
nNiO-MWCNT/ITO electrode (Fig. 3(ii)), may perhaps be attribu-
ted to the covalent attachment of the bienzyme molecules to the film
surface. In particular, the COOHgroup percentage decreased to 2.7%
from the nNiO-MWCNT/ITO film’s value of 13%, indicating that
most of the COOH functional groups are used in bienzyme attach-
ment (ChEt-ChOx). The deconvoluted peak observed at approxi-
mately 282 eV in both of the spectra may be due to the adsorption
of nNiO to the MWCNTs in the sample. In Figure 3(iv), the typical
binding energy peak observed at 398.2 eV is due to the core-level
electron of N1s. The peak found at 400.3 eV for the ChEt-ChOx/
nNiO-MWCNT bioelectrode corresponds to the amide nitrogen
(CO-NH) present in the bienzyme molecules, whereas the peak
Figure 2 | (i) The X-ray diffraction pattern of nNiO-MWCNTs and (ii) the Raman spectroscopy spectra of the NiO nanoparticles (a) and nNiO-
MWCNTs (b).
www.nature.com/scientificreports
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observed at 401.7 eV, attributed to the ;N species, confirms cova-
lent functionalization. The value of the average surface potential of
colloidal NiO nanoparticles was estimated to be 122.7 mV using
zeta potential measurements. This value reveals that the NiO nano-
particles are positively charged (Supporting Information, Fig. S1(a)).
The average surface potential of the MWCNTs was measured to be
26.7 mV, indicating the presence of negatively charged groups on
the sidewalls of the carbon nanotubes (Supporting Information, Fig.
S1(b)). The positively charged nNiO provides strong electrostatic
interactions that link it to the negatively charged MWCNTs.
The scanning electron micrograph (SEM) studies (Fig. S2) were
carried out as a morphological observation study at an accelerating
voltage of 20 kV. The SEM image (Supporting Information, Fig.
S2(i)) shows COOH-functionalized MWCNTs that are likely to be
randomly oriented on the ITO substrate. The in situ incorporated
MWCNTs, with deposited nNiO, are shown in Figure S2(ii). The
NiO nanoparticles appear to be attached to theMWCNTs, which are
not agglomerated, indicating that the presence of NiO nanoparticles
prevented their agglomeration. The transmission electron micro-
scopy (TEM) image shows spherical NiO nanoparticles with an aver-
age size of ,70 nm (Fig. 4(i)). The high-resolution image of the
individual MWCNTs shows outer and inner diameters of 34 and
12 nm, respectively. The selected area electron diffraction (SAED)
pattern shows that graphitic (002) and (004) reflections are present in
the MWCNTs (the inset in Figure 4(ii)). Figure 4(iii) shows that the
well-dispersed COOH-functionalized tubular-shapedMWCNTs are
entangled with NiO nanoparticles and randomly oriented. It appears
that some of the NiO nanoparticles are aggregated on the MWCNT
surfaces. A few NiO nanoparticles can be observed inside the carbon
nanotubes (Fig. 4(iii), marked with dotted lines). The length range of
the MWCNTs is several tens of micrometers, and they have an
external diameter of approximately 20–80 nm. From the atomic-
scale image of the nNiO-MWCNTs (Fig. 4(iv)), it can be concluded
that this nanocomposite is crystalline in nature, with an interlayer
spacing of 3.41 A˚ (d002 for MWCNT, shown in the subfigure inset).
The lattice fringe spacing of the NiO nanocrystal is estimated to be
2.0 A˚, which agrees with the results of the XRD studies. These results
clearly reveal a successful formation of the nNiO-MWCNT compos-
ite, which can be used to fabricate the desired biochip.
The electrochemical behavior of the biochip, both before and after
undergoing surfacemodification by the bienzyme (ChEt-ChOx), was
investigated using cyclic voltammetry (CV) in phosphate buffer sal-
ine (PBS, pH 7.0) containing ferro/ferri cyanide (as a mediator) at a
scan rate of 30 mV/s (Fig. 5(A)). The CV of the nNiO/ITO electrode
Figure 3 | (i) The wide-scan X-ray photoelectron spectra (XPS) of various films. (ii) The XPS spectra of the C1s region of the nNiO-MWCNT film after
deconvolution; (iii) the C1s region of the ChEt-ChOx/nNiO-MWCNT/ITO film; and (iv) the N1s core-level spectra of the ChEt-ChOx/nNiO-MWCNT/
ITO film.
Table I | The atomic concentration (%) of the elements C, Ni, O, and N present in the nNiO-MWCNT/ITO and ChEt-ChOx/nNiO-
MWCNT/ITO films obtained from XPS analysis
Elements/atomic concentration (%) C Ni O N
nNiO-MWCNT/ITO 12.52 33.72 53.76
ChEt-ChOx/nNiO-MWCNT/ITO 59.11 3.88 27.08 9.93
www.nature.com/scientificreports
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exhibited well-defined oxidation/reduction peaks in the 20.8 V to
10.9 V potential range, with a peak-to-peak separation (DE) of
0.115 V (a). After the nNiO was incorporated into the MWCNTs
(1.0%) (b), the electrochemical current increased to 28.0 mA because
MWCNTs are more conductive than the nNiO/ITO electrode alone
(23.0 mA). The large number of edge plane sites along the surface of
the tubes, as well as the presence of defects in the MWCNTs,
enhanced the electrochemical behavior. In addition, the outer and
inner surfaces of the carbon nanotubes were accessible to the elec-
trolyte solution containing Fe31/Fe21 ions and became pathways for
the transport of electrons toward the electrode, resulting in an
enhanced faradic current. In the case of the nNiO-MWCNT(2.0%)
/ITO electrode (c), the peak current increased to 31.2 mA. This
increase is due to the presence of a large number of defect sites in
the MWCNTs, leading to enhanced heterogeneous electron transfer.
The resulting current can be controlled by varying the MWCNT
concentration in the nNiO matrix. Furthermore, a redox current of
14.0 mA was obtained for the nNiO-MWCNT(2.0%)/ITO electrode
after bienzyme functionalization (d), which is lower than that of the
nNiO-MWCNT/ITO electrode; the bienzyme has insulating prop-
erties that block the transport of electrons toward the electrode. The
magnitudes of the cathodic and anodic peaks increased linearly with
the square root of the scan rate (30 to 100 mV s21), indicating a
diffusion-controlled or quasi-reversible process and favourable elec-
tron transfer kinetics (Supporting Information, Fig. S3). The values
of the slope, intercept, and correlation coefficient of the ChEt-ChOx/
nNiO-MWCNT/ITO bioelectrode can be estimated using Eq. (1)–
(4).
Ipa~6:71 mAz3:55 mAmV
{1s
 1=2
scan rate mV=sð Þ½ 1=2; R2~0:999
ð1Þ
Ipc~{0:137 mA{2:56 mAmV
{1s
 1=2
scan rate mV=sð Þ½ 1=2; R2~0:997
ð2Þ
Epa~0:368 Vz1:95 s
1=2 scan rate mV=sð Þ½ 1=2; R2~0:998 ð3Þ
Epc~{0:235 V{1:54 s
1=2 scan rate mV=sð Þ½ 1=2; R2~0:993 ð4Þ
The anodic peak potential (Epa) varied linearly with the natural
logarithm of the scan rate (ln n) and followed Eq. (5).
Epa~0:232 ln nz1:509 ð5Þ
The surface concentration of the ChEt-ChOx/nNiO-MWCNT/ITO
bioelectrode was estimated using Laviron’s theory (Eq. 6), and the
slope is given by Eq. (7):
RT=anF~0:232 ð6Þ
Ip~n
2F2I

4RT ð7Þ
where a is the transfer coefficient, n is the number of electrons
transferred (1 in this case), F is the Faraday constant (96485.34 C/
mol), I* is the surface concentration of the ChEt-ChOx/nNiO-
MWCNT/ITO bioelectrode, n is the scan rate (mV s21), R is the
gas constant (8.314 J mol21 K21), and T is the absolute temperature
(298 K). The ip/n value can be calculated from the slope of the ip
versus n plot. The total surface concentration of the ChEt-ChOx/
nNiO-MWCNT/ITO bioelectrode was found to be 11.07 3
1026 mol/cm2, indicating a high coverage of ChEt-ChOx on the
nNiO-MWCNT/ITO surface.
The flow rate was optimized for the ChEt-ChOx/nNiO-MWCNT
microfluidics biochip using the chronoamperometric technique
(inset of Fig. 5(A)). The chronoamperometric current response of
the nNiO-MWCNT/ITO (i) and ChEt-ChOx/nNiO-MWCNT/ITO
(ii) electrodes was obtained as a function of the flow rate (0.01–
10 mL/min) and the corresponding current versus time, and the plots
are shown in Figures S4 and S5 (Supporting Information), respect-
ively. The chronoamperometric current increases for the nNiO-
MWCNT/ITO electrode with an increasing buffer solution flow rate.
The maximum current is 0.1 mL/min, after which point it reaches
Figure 4 | The HR-TEM analysis of (i) the NiO nanoparticles, (ii) an individual MWCNT (inset: the SAED pattern of the MWCNT), (iii) the MWCNTs
modified with NiO nanoparticles, and (iv) an atomic-scale image of a nNiO-MWCNT (inset: lattice fringes of the MWCNT).
www.nature.com/scientificreports
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saturation (i). This pattern is perhaps due to the diffusivity of the
redox species, which increases with a higher buffer flow rate because
of the improved mass transport. At a flow rate of 0.1 mL/min, the
response time of the microfluidics electrode is 2 s, after which point
the amperometric current becomes saturated (Supporting Informa-
tion, Fig. S4). After its ChEt-ChOx functionalization, the nNiO-
MWCNT/ITO electrode (inset of Fig. 5A(ii)) showed a high initial
current that decreased as the flow rate increased (Supporting
Information, Fig. S5). This response may be attributed to the reten-
tion time of the biocatalytic reaction. As the flow rate increases, the
retention time becomes shorter, resulting in a decreased response
current. It appears that the cholesterol molecules move away from
the biochip-sensing surface prior to the completion of the biochem-
ical reaction. The diffusion time was maximized (approximately 3 s)
at a flow rate of 1.0 mL/min, so the chronoamperometric measure-
ments were carried out at this optimum flow rate. These results
indicate that the fluid flow through the rectangular microchannel
is laminar due to the low Reynolds number (0.082).
Electrochemical impedance spectroscopy (EIS) studies were car-
ried out by applying a small-amplitude sinusoidal AC signal (with a
bias voltage of 0.35 V) as a function of the frequency (0.01 to 105 Hz)
(Fig. 5(B)) using a frequency response analyzer (FRA). The electrical
impedance (Z) is the ratio of the incremental change in voltage, V(t),
to the resulting change in current, I(t), and Z is given by Eq. (8).
Z~
V tð Þ
I tð Þ ~
1
Y
~
V0 sin 2pf tð Þ
I0 sin 2pf tzQð Þ ð8Þ
where V0 and I0 are the maximum voltage and current signals,
respectively, f is the frequency, t is the time, Q is the phase shift
between the voltage-time and current-time function, and Y is the
complex admittance. The impedance is described either by the
modulus Zj j and the phase shift Q or by its real (Z9) and imaginary
(Z0). The most frequently used equivalent circuit for modeling the
EIS experimental data is the Randles circuit (inset of Fig. 5(B)), which
contains the electrolyte resistance (RS) in series with a double-layer
capacitance (Cdl), charge-transfer resistance (RCT), and Warburg
impedance (Zw). The Nyquist plot includes a semicircle region lying
on the real axis, which is followed by a straight line. The linear
portion (Q 5 p/4), observed in the low-frequency range, implies a
mass-transfer limited process; the semicircle portion, observed in the
high-frequency range, implies a charge-transfer-limited process. The
imaginary component decreases to zero at a high frequency because
it offers no impedance. As the frequency drops, the capacitance (Cdl)
offers higher impedance and the current flows primarily through the
RCT and RS segments. The RCT value of the nNiO-MWCNT/ITO
electrode is 1.9 kV (shown in curve b), which is lower than the value
of the nNiO/ITO electrode (19 kV; curve b). This result is due to the
presence of the MWCNTs, which cause enhanced catalytic activity
Figure 6 | (i) The chronoamperometric response of the ChEt-ChOx/nNiO-MWCNT/ITO-based biochip as a function of the cholesterol oleate
concentration (0.25–12.93 mM) in a PBS solution containing 5 mMof [Fe(CN)6]
32/42. The experiment was controlled using a syringe pump attached to
the inlet of themicrosystem (inset: the response current as a function of the cholesterol concentration obtained for both (a) ChEt-ChOx/nNiO-MWCNT/
ITO and (b) nNiO-MWCNT/ITO electrodes). (ii) A calibration plot showing the logarithm of the cholesterol concentration (mM) and the amperometric
current of the biochip during sensing.
Figure 5 | (A) A cyclic voltammogram (CV) of the different electrodes in a PBS solution (50 mM, pH7.0, 0.9%NaCl) containing 5 mMof [Fe(CN)6]32/42
(inset: current versus flow rate plot of the chronoamperometric response). (B) The electrochemical impedance spectroscopy (EIS) spectra of the
electrodes (inset: a schematic representation of the Randles equivalent circuit model for impedance measurement).
www.nature.com/scientificreports
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and favorable electron-transfer kinetics; improved kinetics leads to a
greater diffusion of the Fe21/31 ions from the bulk solution to the
electrode surface. The RCT value of the ChEt-ChOx/nNiO-MW-
CNT/ITO bioelectrode increases to 3.9 kV (curve c), a value greater
than that of the nNiO-MWCNT/ITO (curve b) electrode, implying
that the bienzyme absorbed onto the nNiO-MWCNT surface pro-
vides steric hindrance to the diffusion of electrons through the elec-
trode-electrolyte interface.
Discussion
The successful formation of the nNiO-MWCNT composite and its
bienzyme functionalization were confirmed via XRD, Raman, XPS,
SEM, and TEM studies. The chronoamperometric response of the
biochip (ChEt-ChOx/nNiO-MWCNT/ITO) was measured (Fig. 6(i))
as a function of the cholesterol oleate concentration (0.25–
12.93 mM). During this chronoamperometric measurement, the
solutions containing various concentrations of cholesterol oleate in
PBS were injected through an inlet of the microchannel at regular
intervals. The sensing potential was maintained at 20.4 V during
the measurements, when the specific oxidative reaction of the bien-
zyme ChEt-ChOx was dominant. The chronoamperometric current
of the microfluidics biochip increased linearly in the range of 0.25–
12.93 mM, after which point it was saturated (inset, Fig. 6(i)a). First,
esterified cholesterol was converted into fatty acids and cholesterol in
the presence of ChEt. ChOx molecules containing flavin-adenine-
dinucleotide (FAD) sites reacted with the cholesterol to produce
cholesterol-4-ene-3-one and H2O2 via catalytic conversion. The pro-
duced H2O2 further oxidized to H2O and oxygen by losing two
electrons. These generated electrons (not mediated electrons) are
responsible for the enhanced chronoamperometric current that
was observed, and the current is directly proportional to the concen-
tration of the injected esterified cholesterol. The enzymatic reactions
used for total cholesterol detection are given by Eq. (9–10).
Cholesterol OleatezCholeaterol Esterase?
Fatty AcidzCholesterol
ð9Þ
CholesterolzCholeserol Oxidase?
Cholest{4{ene{3{onez2e{
ð10Þ
A control experiment was conducted using the nNiO-MWCNT/
ITO electrode without bienzyme functionalization under similar
conditions (inset, Fig. 6(i)b). The current versus time response plot
of this control experiment is shown in Figure S5 (Supporting
Information). We did not observe any significant change in the cur-
rent response of the nNiO-MWCNT/ITO electrode with increasing
concentrations of esterified cholesterol. These results reveal that the
nNiO-MWCNT/ITO electrode surface did not react with the esteri-
fied cholesterol molecules, and therefore, the electrochemical current
remained unchanged.
Table II shows the characteristics of the fabricated microfluidics
biosensor along with those reported in the literature for other
devices. It can be observed that the nNiO-MWCNT composite-based
microfluidics biodevice exhibits a much higher sensitivity (2.2 3
103 mA/mM/cm2), lower response time (2 s), lower Kappm (0.22 mM),
and more extended linearity (0.25–12.93 mM) than other total cho-
lesterol sensor reported in the literature33,35–37. The observed low Kappm
value, obtained using the Lineweaver-Burk plot (1/concentration vs.
1/current) and the best linear fit (Table II) indicates that ChEt-ChOx
has a high affinity for cholesterol oleate and was properly functio-
nalized onto the nNiO-MWCNT surface. The 20-fold higher sens-
itivity, 2.2 3 103 mA/mM/cm2, may be due to the integration of the
high-aspect-ratio microfluidics device with the nNiO-MWCNT
matrix, as well as an improved biofunctionalization of the bienzyme.
The composite material (nNiO-MWCNT) has enhanced electro-
chemical properties, and the micro-dimensions of the fabricated
electrode can cause improved electron diffusion. Additionally, the
MWCNTs provide a channel for electron conduction with long
electron mean free paths toward the electrode and thus have the
capability to support very large current densities. The detection limit
of this nanobiochip was found to be a cholesterol concentration of
0.033 1023 M, which corresponds to a physiological range of 2.07–
6.2 mM in human blood. The comparatively higher detection limit
Table II | The sensing characteristics of the nanomaterial-based biochip designed for total cholesterol estimation
Electrode materials
Microfluidic
used
Detection
limit (M)
Sensitivity
(/mM/cm2) Detection range
Km Value
(mM)
Stability
(days) Ref.
CNT Yes 0.253 1023 0.0512 nA 1.25–10.0 mM …… …… 18
Anatase-TiO2 Yes 1.23 1023 0.094 mA 0.64–10.3 mM 0.14 mM 35 34
nNiO Yes 0.653 1023 0.12 mA 0.64–10.3 mM 0.16 mM 60 26
ZnO No 373 1029 23.7 mA 1.0 to 500.0 nM 4.7 mM 50 35
Pt nanoparticles No 0.23 1026 2.07 mA Upto 4.0 mM 5 mM 3 36
Polyelectrolyte-MWCNT No 0.23 1023 0.559 mA Upto 6.0 mM 7.17 mM …… 37
Chitosan/silica-MWCNT No 13 1026 1.55 mA 4.0 mM–0.7 mM 0.24 mM 50 33
nNiO-MWCNT Yes 0.033 1023 2.2 mA 0.25–12.93 mM 0.22 mM 40 Present Work
Figure 7 | (i) Reproducibility studies of the ChEt-ChOx/nNiO-MWCNT/ITOmicrofluidics bioelectrodes under similar conditions. (ii) Stability studies
of the ChOx-ChEt/nNiO-MWCNT/ITO bioelectrode and (iii) selectivity studies of the ChOx-ChEt/nNiO-MWCNT/ITO-based biochip.
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of the ChEt-ChOx/nNiO-MWCNT/ITO microfluidics total choles-
terol sensor may be caused by either insufficient electrical conduc-
tivity of the nNiO or the morphological changes arising as a result of
interactions between the bienzyme (ChEt-ChOx) and the nNiO-
MWCNT nanocomposite surface18,26,34,37.
Our biochip shows good reproducibility for cholesterol concen-
trations of 2.59 and 5.18 mM (Fig. 7(i)) as is evidenced by the low
standard deviations (RSD) found (4.19% and 2.13%, n 5 5), indi-
cating good precision. The ChEt-ChOx/nNiO-MWCNT/ITO bioe-
lectrode also shows good repeatability, as evidenced by its lowRSD of
1.12% (n 5 15) for a cholesterol concentration of 2.50 mM. No
significant decrease in the current was observed after 12 uses; in
further procedures, the bioelectrode showed slight decreases in its
current response due to the denaturation of the biomolecules (Fig. 7
(ii)).
The selectivity of the ChEt-ChOx/nNiO-MWCNT/ITO bioelec-
trode was demonstrated using lactic acid (LA), glucose (G), ascorbic
acid (AA), uric acid (UA), and other interferents in a buffer solution.
We found that the present bioelectrode is highly specific to total
cholesterol (5.18 mM) and shows a negligible change in its response
current in the presence of other analytes (interferents) (Fig. 7(iii)).
The shelf life of this biochipwas determined bymeasuring the change
in the current response at regular 5-day intervals for approximately 3
months; the chip exhibited a 93.7% response after approximately 40
days (data not shown). The ChEt-ChOx/nNiO-MWCNT/ITO bioe-
lectrode was stored at 4uC when not in use. This integrated micro-
fluidics nanobiochip reached 92% of its steady-state current in less
than 2 s, indicating that a fast electron exchange was occurring
between the active sites of the bienzyme and the nNiO-MWCNT/
ITO electrode.
In summary, our miniaturized microfluidics-integrated biochip
based on a nNiO-MWCNT composite allows for the rapid detection
of biomolecules at a low cost. The nNiO serves as a support for the
dispersion of MWCNTs and helps exfoliate smaller bundles or indi-
vidual nanotubes. The covalent functionalization through reactions
of desired chemical groups onto the p-conjugated skeleton of this
nNiO-MWCNT composite matrix offers considerable advantages
for the development of a nanobiochip to detect molecules such as
cholesterol. In particular, the COOH groups on the MWCNTs pro-
vide simple biofunctionalization and a higher loading capacity of
biomolecules on the microfluidic transducer surface. The 9.3% of
the carboxyl groups that were present on the nNiO-MWCNT surface
were used to covalently bind with the bienzyme. The synergistic
electrocatalytic activity of the MWCNTs provides straight conduct-
ing pathways for carriers such as electrons and ions, resulting in a
higher sensitivity than nNiO-based biochips. This bienzyme functio-
nalized and integrated microfluidics biochip was highly sensitive to
cholesterol oxidation and was both highly reproducible and stable,
allowing it to be utilized for total cholesterol monitoring. Our plat-
form exhibits improved detection limits and a faster response time.
This highly efficient composite microfluidics biochip could be used
to create an array-based biochip that simultaneouslymonitorsmulti-
analytes, including low-density lipoproteins and triglycerides, mak-
ing it a promising platform for biomedical applications.
Methods
Nickel nitrate [Ni(NO3)2]?H2O and potassium hydroxide (KOH) were procured
from Sigma-Aldrich, USA. N-hydroxisuccimide (NHS), N-ethyl-N9-(3-dymethyla-
minopropyl carbodiimide) (EDC), cholesterol oxidase (ChOx), cholesterol esterase
(ChEt), and cholesterol oleate were purchased from Sigma-Aldrich, USA. Different
concentrations of cholesterol oleate, from 0.25 to 12.93 mM, were prepared in 0.9%
NaCl solution. SU8-100 negative photoresist and SU-8 developer were purchased
from Microchem (Newton, MA, USA).
Instrumentation. The nanostructured nickel oxide (nNiO) and the nNiO-MWCNT
matrices were characterized using X-ray diffraction (XRD, Cu Ka radiation, Rigaku),
Raman spectroscopy, and transmission electron microscopy (TEM; JEOL JEM-2000
EX). The XPS measurements were performed using an X-ray photoelectron
spectrometer (XPS, Multilab 2000, Thermo Scientific) equipped with an alpha 110
hemispherical electron energy analyzer and an X-ray source. The XPS measurements
were made in the binding energy range of 0–1100 eV to confirm the ChEt-ChOx
functionalization of the nNiO-MWCNT matrix. The electrochemical studies were
performed using an electrochemical analyzer (AUT-84275) in PBS at pH 7.0
containing 5 mM of [Fe(CN)6]32/42 as a redox species.
PDMSmicrochannel fabrication. The three rectangular PDMSmicrochannels were
fabricated using the soft lithography technique26. The channel height and width were
each 200 mm, and the length was 2.0 cm. The microchannels had reservoirs at the
end, which were fabricated by punching holes in the PDMS slab at the desired
position. The three fabricated channels were connected to reservoirs via a single inlet
and outlet (Fig. 1(i)). The principal reason to use three channels is to increase the
sensor surface area of the biochip.
Microelectrode fabrication.The indium tin oxide (ITO)-coated glass substrate (with
a thickness of approximately 150–300 A˚) had a sheet resistance of 70–100 V and was
used to fabricate the microelectrode (0.63 0.26 cm2) via wet chemical etching. The
masked ITO was dipped in ITO etchant solution (HNO3:HCl:H2O in a 1510510
ratio) for 15 min, and ITO was selectively etched from the glass substrate. The ITO
electrode was cleaned with acetone and then sonicated with acetone (10 min) and
water (2 min) several times. The glass substrate containing the electrodes was
hydrolyzed using a mixture of H2O5H2O25NH3 (55151) and washed with deionized
water. It was then dried in an oven at 100uC for approximately 4 h.
Synthesis of the nNiO-MWCNT composite.TheMWCNTs (90%) were synthesized
by catalytic chemical vapor deposition using amixture of ferrocene as the catalyst and
toluene as the hydrocarbon source31. These MWCNTs were purified and
functionalized by refluxing in a concentrated solution of nitric acid and sulfuric acid,
which generated a large number of COOH groups on the nanotube surfaces32. The
drop-wise addition of 0.2 M KOH solution and COOH-terminated MWCNTs to a
solution of 0.5 M Ni(NO3)2?6H2O (nickel nitrate) in de-ionized water with constant
stirring results in a blackish-green precipitate of nickel hydroxide, Ni(OH)2, at a pH of
approximately 11.8. Excess solvents were evaporated to obtain the precipitate, which
was dried at 80uC for 24 h to create a transparent viscous solution of nickel
hydroxide-modified MWCNTs. This precipitate was maintained at a pH of 10.0. The
thick gel-like Ni(OH)2-modified MWCNT solution was deposited onto patterned
ITO electrodes on the glass substrate via dip coating. The electrodes were initially
dried at approximately 110uC for 1 h, and they were then annealed at 400uC under
ambient conditions for approximately 2 h to remove any solvent, causing the nNiO-
MWCNTs (weight 1.0%) and nNiO-MWCNTs (weight 2.0%) to adhere to the ITO
surface.
Functionalization of the bienzyme (ChEt-ChOx).Amixture of ChEt (1 mg/ml) and
ChOx (1 mg/ml) in a 151 ratio was spread onto the nNiO-MWCNT/ITO
microelectrode through physical absorption (Fig. 1(i)); the electrode was then kept in
a humid chamber for 4 h at room temperature (298 K). The carboxyl-terminated
MWCNTs and the NiO nanoparticles are negatively and positively charged,
respectively, resulting in increased electrostatic interactions. However, the carboxylic
groups can undergo an amidation reaction with the amino acids of proteins. One
approach to covalently bind proteins or enzymes utilizes the diimide-activated
amidation of carboxylic acid functionalized carbon nanotubes. The COOH terminal
group was activated using EDC (0.4 M) as the coupling agent andNHS (0.1 M) as the
activator. The formation of strong covalent (C-N) amide bonds between the COOH
groups of the MWCNTs and the NH2 groups of the bienzyme (Fig. 1(i)) was
confirmed via XPS studies. It is possible that the nNiO molecules with a high
isoelectric point (an IEP of 10.0) interact with the bienzyme directly through
electrostatic interactions due to their low IEP (5.5).
Microfluidics biochip integration. A lithographically fabricated rectangular PDMS
microchannel slab was sealed temporarily (irreversible) with the ITO glass substrate
using a conformal contact38 that contained the modified nNiO-MWCNT and ChEt-
ChOx electrodes (Fig. 1(i). The photograph of real microfluidic nanobiochip for
cholesterol detection is shown in Fig. 1(ii). Fig. 1(iii) shows the enlarged view of
optical microscopic image of this microfluidic nanobiochip. The PDMS surface
provides an adhesive layer that plays an important role, making the bonding with the
glass substrate irreversible through weak Van der Waals forces38. Again, the inlet
reservoir of the PDMS microchannel was used to introduce the syringe pump, which
was based on a stepped motor, to control the fluid flow in the microfluidics biochip.
The outlet reservoir was used to accommodate an Ag/AgCl wire that served as the
reference electrode (RE). The bare ITO acted as the counter electrode (CE), and the
ChEt-ChOx/nNiO-MWCNT/ITO bioelectrode was used as a sensor for total
cholesterol detection. All of these three electrodes contained a glass substrate and
PDMS microchannels and were embedded on the same biochip.
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